Vaccitech plc (VACC)
After hours:
- GlobeNewswire
Vaccitech Appoints Industry Veteran, Nadège Pelletier, Ph.D., as Chief Scientific Officer
Nadège Pelletier, Ph.D., Chief Scientific Officer Nadège Pelletier, Ph.D., Chief Scientific Officer Dr. Pelletier joins leadership team to continue the advancement of Vaccitech’s diverse clinical pipeline and partnerships, bringing more than 15 years’ experience in pharmaceuticals and academia in immunology and infectious diseasesFormer CSO, Dr. Tom Evans to continue supporting company as a consultant OXFORD, United Kingdom, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Vaccitech plc (NASDAQ: VACC), a clini
- Simply Wall St.
Vaccitech (NASDAQ:VACC) adds US$10m to market cap in the past 7 days, though investors from a year ago are still down 73%
Vaccitech plc ( NASDAQ:VACC ) shareholders should be happy to see the share price up 16% in the last month. But that is...
- GlobeNewswire
Vaccitech to Host KOL Webinar on the SNAPvax™ Platform for Inducing Tolerance to Treat Celiac and other Autoimmune Diseases
OXFORD, United Kingdom, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Vaccitech plc (NASDAQ: VACC) today announced that it will host a Key Opinion Leader (KOL) webinar on its SNAPvax™ Platform and application in tolerogenic immunotherapies for celiac disease and other autoimmune diseases on Monday, November 28, 2022 at 4:30 pm ET. Vaccitech is a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infec
